ACT latest jurisdiction to reduce AZ dosing interval The COVID outbreak in Canberra means people can get a second dose of AstraZeneca after 4–8 weeks. What does this mean for efficacy?
Delta raises COVID reinfection risk by 46%: Study But figures suggest the overall probability remains relatively low and does not increase until 180 days after the first infection.
Australia’s neighbours being ‘overwhelmed’ by Delta surge Even countries that had successfully contained previous outbreaks – like Vietnam, which last week recorded a 546% increase in deaths – are struggling with exploding case numbers.
CDC COVID report ‘no cause for panic’ A new study suggesting vaccinated and unvaccinated people who contract COVID have similar viral loads has been questioned.
How are COVID vaccines faring against Delta? New insights from the UK and Israel suggest first generation vaccines may not be as effective, but it’s not all doom and gloom.
Are vaccines keeping up with Delta? The efficacy of vaccines against the latest variant of concern is under intense scrutiny. Here’s what the latest studies have found.
Vaccines ‘highly effective’ among majority of at-risk groups: UK study The research relied on results from more than 700 general practices and addresses a previously unresolved information gap.
Herd immunity likely to be ‘made harder’ by variants New modelling has underlined the increasing scale of Australia’s vaccination challenge as it aims to open up to the world.
How Delta presents differently to other COVID strains The symptoms of the Delta variant appear to differ from traditional COVID symptoms. Virologist Lara Herrero explains what to look out for.
Is Australia ready for the COVID Delta variant? With cases emerging in most states and territories, experts are concerned Australia is ill-prepared.